MicroPort Sets March 31 Board Meeting to Approve 2025 Final Results

The latest announcement is out from MicroPort Scientific ( (HK:0853) ).

MicroPort Scientific Corporation has scheduled a board meeting for 31 March 2026 to review and approve the group’s audited financial results for the year ended 31 December 2025. The meeting will also address other corporate matters, signaling the next key milestone in the company’s financial reporting cycle and providing investors with a forthcoming update on its operational and financial performance.

The announcement formally confirms the timetable for disclosure of the company’s final results, giving the market clarity on when full-year figures will be considered by the board. This step is a routine but important part of MicroPort Scientific’s governance processes, as it precedes the release of detailed annual results that inform shareholders and other stakeholders about the company’s recent business trajectory and strategic execution.

The most recent analyst rating on (HK:0853) stock is a Hold with a HK$12.50 price target. To see the full list of analyst forecasts on MicroPort Scientific stock, see the HK:0853 Stock Forecast page.

More about MicroPort Scientific

MicroPort Scientific Corporation is a medical technology company based in Shanghai and incorporated in the Cayman Islands, focusing on the development and manufacture of innovative medical devices. Listed on the Hong Kong Stock Exchange, the group operates through multiple subsidiaries and is overseen by a board comprising executive, non-executive and independent non-executive directors.

Average Trading Volume: 15,085,466

Technical Sentiment Signal: Sell

Current Market Cap: HK$20.05B

See more insights into 0853 stock on TipRanks’ Stock Analysis page.